Writing
Articles
These articles were written over several years, in no particular order. They are organised here against the Proof Stack, the structure that More Scars Than Trophies uses: the evidence a company owes itself at each stage, and the decisions that evidence unlocks. Read the framework first if you have not seen it.
Start here
Three reading paths
If you only have ten minutes, start with the first article in your path.
Founders
Investors
Boards
Foundations
- There’s a quiet truth in the startup world that rarely makes headlines: most successful technology companies never raised venture capital.
- Treat building a startup like a disciplined probability game: reduce variance, expose problems early, and increase your odds.
- Signals bend under pressure, and founders are not neutral observers of their own company.
- The camel path is a choice of route. It says nothing about how big the destination can be.
- The usual answer to stress is to do more. In my experience that is the wrong answer, and it makes the stress worse.
Discovery
- Founders walk into critical decisions asking: When do I raise? How big should my round be? Which VC should I approach? These are the wrong questions.
- Most founders misunderstand the problem they think they’re solving. Problem-solution fit is not a milestone. It’s a discipline.
The Proof Stack layers
Buyer Proof
Who pays?
- If the problem disappears when your startup disappears, you never had a problem. You had a hypothesis. And the market does not fund hypotheses.
Value Proof
What value survives?
- Founders price the value they create. Buyers price what is left after the cost of change, and that cost is usually personal.
- More scars than trophies, and most of those scars came from founders selling too cheap.
- When the product itself stops being defensible, buyer-by-buyer understanding of who actually pays, why, and what survives their real cost of change becomes close to the only moat left.
- AI does not need to invent anything to mislead a founder. Only the customer can tell you what this organisation will have to go through before the value arrives.
Scaling Proof
What repeats and scales?
- The company hadn’t scaled revenue. It had scaled uncertainty, with a bigger payroll attached to it.
- Two experienced salespeople, six months, zero buying customers: why founders wait, and why money makes it worse.
- Most founders treat scaling as a growth problem. Across the 220+ startup companies I have backed, it is more often a segment problem.
Exit Proof
Who buys?
- 82–88% of successful startup exits in the Nordics never raised a single euro of VC.
- Valuation is not a spreadsheet exercise. It’s buyer psychology mixed with incentives.
- Every operating number said it was working. The company hadn’t gotten worse. The market’s confidence in the story had.
- Most founders dream of a trade-sale exit. Very few understand what actually happens after the signatures dry.
- Most founders think dilution is the risk they're managing when they raise. The actual risk is raising past what you've actually proven.
- In the cases I've seen, the preparation started when the buyer showed up. It has to start years earlier, because the founder does not control the timing.
- In most cases a VC round buys dilution, not company value growth. The founder ends up owning less of a company that is not worth proportionally more.
Governance
- Most startup boards don’t fail because they give bad advice. They fail because they convert good advice into premature action, and call it governance.
- Ambition is not about dreaming; it has to be backed with deep knowledge, and it rarely is.
- It sits in a folder for years, and then it comes out on two kinds of days: in times of trouble, when shareholders fight, and in times of happiness, when the company is sold.
Investor Lens
- Most of the money I’ve lost wasn’t lost because the founders were bad. It was lost because the math was broken on day one.
- Advice from an investor who has backed 220+ startup companies and seen 20+ positive exits, so other investors would not make the same costly mistakes I have made.
- Two out of three venture investors never back a single big winner. Repeat 5x exits come from capital-efficient companies and a strategy written before the investment.
- Ten rounds of dilution leave the first angel 13% of the stake. The entry valuation is the one number the angel sets, and it is set on the day the money goes in.
- The 88% is a statistic about founders. For the angel sitting one line above them, it is the base rate.
Ecosystem & Market
- The real European startup economy, the one that actually creates value, is built by companies the headlines ignore.
- A €50M round is visible. A €5M ARR company with 30% EBITDA is valuable. Those two things are not interchangeable.
Disagree with something here, or want it covered from another angle? Send a short note.